31/08/2022 |
NOSIUM AB (publ) |
Daniel Ehdin |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
NOSIUM B |
Share |
SE0017564271 |
31/08/2022 |
31,820 |
Quantity |
0.95 |
SEK |
|
Notification
|
31/08/2022 |
Stayble Therapeutics AB |
Andreas Gerward |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Stayble Therapeutics AB |
Share |
SE0013513652 |
31/08/2022 |
15,000 |
Quantity |
4.89 |
SEK |
|
Notification
|
31/08/2022 |
Intervacc AB |
Jan Persson |
Chief Financial Officer (CFO) |
|
Acquisition |
Intervacc AB |
Share |
SE0009607252 |
31/08/2022 |
4,000 |
Quantity |
32.00 |
SEK |
|
Notification
|
31/08/2022 |
Lipigon Pharmaceuticals AB |
Stefan Nilsson |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Lipigon Pharmaceuticals AB |
Share |
SE0015382072 |
31/08/2022 |
35,590 |
Quantity |
1.91 |
SEK |
|
Notification
|
31/08/2022 |
Bambuser AB |
Sofie Abrahamsson |
Other member of the company's administrative, management or supervisory body |
|
Subscription |
Bambuser AB |
Share |
SE0009663834 |
15/08/2022 |
431,403 |
Quantity |
0.75 |
SEK |
|
Notification
|
31/08/2022 |
Bambuser AB |
Sofie Abrahamsson |
Other member of the company's administrative, management or supervisory body |
|
Allotment |
Bambuser AB |
Option |
SE0009663834 |
26/08/2022 |
245,000 |
Quantity |
0.00 |
SEK |
|
Notification
|
31/08/2022 |
Newbury Pharmaceuticals AB |
Alsakali Equity AB |
Chairman of the Board of Directors |
Yes |
Acquisition |
Newbury Pharmaceuticals AB |
Share |
SE0015244884 |
31/08/2022 |
10,000 |
Quantity |
4.44 |
SEK |
Revised |
Notification
|
31/08/2022 |
TC TECH Sweden AB (publ) |
Jörgen Brandt |
Member of the Board of Directors |
|
Disposal |
TC TECH Sweden AB |
Share |
SE0007603170 |
30/08/2022 |
5,040 |
Quantity |
4.20 |
SEK |
|
Notification
|
31/08/2022 |
Oncopeptides AB |
Per Wold-Olsen |
Chairman of the Board of Directors |
|
Acquisition |
Oncopeptides AB |
Share |
SE0009414576 |
30/08/2022 |
1,029 |
Quantity |
26.89 |
SEK |
|
Notification
|
31/08/2022 |
Oncopeptides AB |
Per Wold-Olsen |
Chairman of the Board of Directors |
|
Acquisition |
Oncopeptides AB |
Share |
SE0009414576 |
30/08/2022 |
1,700 |
Quantity |
26.90 |
SEK |
|
Notification
|